Meters & Monitors
Blood Glucose Meters  Current Continuous Monitors Comparison of Available Monitors 
Various Future Monitors Improving Today's Meters Other Monitors Older Monitors
Future Monitoring
AiMedics A.Menarini Diagnostics Cybiocare OHD InLight Solutions Kumetrix LighTouch Medical NAS - iSense NIR Diagnostics Optiscan Orsense Pindi Products Sensors For Medicine and Science Sensys Medical Sentek Solianis Sontra SpectRx Synthetic Blood International Therasense Visual Pathways
AiMedics - Hypomon  
AiMedics, established in October 2001 as a commercial spin-off of the University of Technology, Sydney (UTS), specializes in non-invasive monitoring for various diseases, including diabetes, epilepsy, fatigue and Sudden Infant Death Syndrome.
One of AiMedics' primary focuses is the development of HypoMon®, a real-time, non-invasive, device that detects low blood glucose levels in people with diabetes who use insulin.
Hypomon™
Similar to the Sleep Sentry, the HypoMon® system attempts to non-invasively detect hypoglycemia symptoms in people with Type 1 and insulin-dependant Type 2 diabetes through contact with the skin. The system alerts when the blood glucose falls below 2.5 mmol/l (45 mg/dl). This alarm allows for the patient and/or care person to treat the hypoglycemia at an earlier stage. The system can be used to monitor glucose levels during the day and while you are sleeping. It will be a helpful device for people who cannot afford a continuous monitor but it is important to know that the device does not measure the actual blood sugar level. It only recognizes and measures the bodies responses to changes in BG levels.
 The HypoMon® system includes a battery powered unit worn on your chest. This unit has four skin surface sensors that measure skin moisture and heart activity, two known symptoms of a low blood sugar. The readings from this chest unit are wirelessly sent to the receiver where the readings can be read. AiMedics has developed a system to take these readings and determine when hypoglycemia reaches a critical stage. .
Some drawbacks from the Sleep Sentry are present in this device as well. For instance, movement or sweat can trigger a false alarm. A particularly hot night or constant tossing and turning can result in many alarms throughout the night.
In January of 2006, AiMedics concluded the pre-clinical studies of the HypoMon® at the Prince of Wales Hospital (Adult population) and at the Princess Margaret Hospital (Children population). Development of the HypoMon® is currently being undertaken to seek regulatory body approval for large-scale clinical data collection.
Click Here to browse our secure, on-line store for a complete selection of diabetes books at 22%-50% off their cover price. You can also download our Diabetes Mall 2008 Catalog, email our Order Form, or call us at (800) 988-4772.
Back to Top 
|
